Why is Ajooni Biotech falling/rising?

As of 24-Jun, Ajooni Biotech Ltd's stock price is currently at 6.03, reflecting an increase of 0.45 or 8.06%. The stock has outperformed its sector today by 7.85%, and its performance over the past week shows a gain of 7.10%. However, despite this positive movement, there is a noted decline in investor participation, with delivery volume falling by 38.15% compared to the 5-day average. The company has reported positive results for the last three consecutive quarters, with net sales growing by 49.49% and a profit after tax reaching its highest at Rs 1.54 crore. The stock is trading at a discount compared to its peers, and it has generated a return of 17.77% over the past year, significantly higher than the market average.
In the broader market context, Ajooni Biotech's short-term performance has been strong, especially when compared to the benchmark Sensex, which has only increased by 0.77% over the same week. However, the stock's year-to-date performance shows a decline of 22.39%, contrasting with the Sensex's gain of 5.92%. While the stock has demonstrated attractive valuation metrics and has outperformed the market over the past year, concerns regarding its long-term fundamental strength, including a low return on capital employed and weak debt servicing ability, may temper investor enthusiasm moving forward.